Seeking Alpha

ACOR
  Acorda Therapeutics, Inc. - NASDAQ

9/17/2014, 12:20 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
ACOR vs. ETF Alternatives
Company Description
Acorda Therapeutics, Inc. is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of multiple sclerosis, spinal cord injury & other disorders of the central nervous system.
Sector: Healthcare
Industry: Biotechnology
Country: United States